drugset / Trial / NCT02225639
PRC-063 in an ADULT Workplace Environment
RandomizedCrossoverTriple-blindTreatment
Summary
The primary objective of this study is to assess the time of onset and time course of efficacy over 16 hours of PRC-063 compared to placebo in adults diagnosed with ADHD in a simulated adult workplace environment (AWE) setting, as measured by the PERMP (an individually-adjusted math test) at pre-dose, 1.0, 2.0, 5.0, 8.0, 11.0, 14.0 and 16.0 hours post-dose.
Timeline
- Start
- 2014-08
- Primary completion
- 2015-04
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | 25 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 35 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 45 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 55 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 70 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 85 mg | Oral |
| Comparator | Methylphenidate | Small molecule | 100 mg | Oral |